ApiFix Receives FDA Approval to Commercialize MID-C System for Motion-Preserving Deformity Treatment of Progressive Idiopathic Scoliosis in Adolescents

Press/Media

Period27 Aug 2019

Media coverage

1

Media coverage

  • TitleApiFix Receives FDA Approval to Commercialize MID-C System for Motion-Preserving Deformity Treatment of Progressive Idiopathic Scoliosis in Adolescents
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date27/08/19
    PersonsBaron Lonner
View all 1
View less